Skip to main content

Type 2 Diabetes News

Type 2 Diabetes is a chronic condition involving high blood sugar levels and reduced production and responsiveness to insulin.     

Unpacking cardiovascular-kidney-metabolic syndrome, its significance in diabetes, heart, and kidney health, plus expert insights on management and self-advocacy.
Diagnosed with type 2 diabetes at 23, Liz Kopco shares her journey from a health-conscious lifestyle to confronting diabetes stigmas and stereotypes, emphasizing the...
Starting on metformin? My journey with type 2 diabetes on learning how to deal with side effects, “faux lows,” and learning more about this therapy.
This article details Mounjaro's efficacy in type 2 diabetes management, highlighting the drug’s ability to significantly reduce A1C and body weight. Read about the...
Discover advancements in diabetic macular edema treatment options, including anti-VEGF therapies and non-invasive drugs, for better management of this vision-threatening...
An international consensus was published on World Diabetes Day in the Lancet on bringing an end to diabetes stigma and discrimination. Join the global movement and sign...
Several trials are studying innovative approaches to help people living with diabetes better manage blood glucose levels with CGM, AID systems, and digital health. Here...
People with diabetes are at higher risk for health issues like chronic kidney disease, diabetic macular edema, and liver disease. Here are clinical trials studying ways...
Discover how automated insulin delivery (AID) benefits type 1 diabetes and ongoing trials assessing the impact of AID systems on type 2 diabetes management.
Orforglipron, Eli Lilly's once-daily oral GLP-1 receptor agonist, is being studied in ongoing clinical trials for obesity and type 2 diabetes. Data shows A1C reductions...
Advances in blood glucose management, weight loss, and heart health are at the forefront of type 2 diabetes research. Here are some exciting new clinical trials you can...
Novo Nordisk is set to discontinue Levemir, a key long-acting insulin, by the end of 2024 due to manufacturing priorities and better alternatives, impacting supply and...
FDA approves Zepbound for obesity management alongside diet and exercise. A promising new option for weight control, it's the second once-weekly injectable after Wegovy...
Clinical trials are the middle step between scientific discoveries in the lab and making these discoveries available to the public. Learn how clinical trials work, the...
The T1DEXI study sheds light on the impact of exercise on type 1 diabetes, including how to manage hypoglycemia and hyperglycemia. In addition, here are some practical...
Explore the VITAL-CGM trial, which investigates if using a combination of CGM and WeightWatchers can lower A1C in people with type 2 diabetes.
Descubre las razones por las cuales los hispanos tienen un riesgo elevado de sufrir diabetes tipo 2 y encuentra consejos de expertos para prevención y manejo de la...
Halloween can be a tricky holiday to navigate. Here are some ways to make trick or treating safe for people with diabetes and some other fun activities to do that don't...
Omnipod 5 users will soon be able to control their AID system through a free iPhone app available in the new year. Like the Android app, iPhone users will be able to...
Explore the link between obesity, diabetes, and breast cancer risk. Learn how treatments like bariatric surgery and medications can reduce this risk and aid in diabetes...

Pages